The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The future of the β-lactams
Open accessAbstract
In the 80 years since their discovery the β-lactam antibiotics have progressed through structural generations, each in response to the progressive evolution of bacterial resistance mechanisms. The generational progression was driven by the ingenious, but largely empirical, manipulation of structure by medicinal chemists. Nonetheless, the true creative force in these efforts was Nature, and as the discovery of new β-lactams from Nature has atrophied while at the same time multi-resistant and opportunistic bacterial pathogens have burgeoned, the time for empirical drug discovery has passed. We concisely summarize recent developments with respect to bacterial resistance, the identity of the new β-lactams, and the emerging non-empirical strategies that will ensure that this incredible class of antibiotics has a future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Cited by
Triazole derivatives and their antiplasmodial and antimalarial activities
Chu, X.-M., Wang, C., Wang, W.-L., Liang, L.-L., Liu, W., Gong, K.-K., & Sun, K.-L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.047 · Cited by 287
Bahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Metadata
- Authors
- Llarrull, L. I., Testero, S. A., Fisher, J. F., & Mobashery, S.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 13
- Issue
- 5
- Pages
- 551-557
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W2060977621
- Cited by
- 170
- References
- 1
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The future of the β-lactams. https://app.cochat.ai/papers/10.1016/j.mib.2010.09.008
- The paper
- Llarrull, L. I., Testero, S. A., Fisher, J. F., & Mobashery, S. (2010). The future of the β-lactams. Current Opinion in Microbiology. https://doi.org/10.1016/j.mib.2010.09.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.